AI assistant
Barclays PLC Major Shareholding Notification 2021
5250_rns_2021-07-02_7c4b347a-56b1-49cf-bea8-944614e2c836.html
Major Shareholding Notification
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
Form 8.3 - WILLIS TOWERS WATSON PLC
Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
| Name of person dealing (Note 1) | Barclays PLC. | |
| Company dealt in | WILLIS TOWERS WATSON PLC | |
| Class of relevant security to which the | ORD | |
| dealings being disclosed relate (Note 2) | ||
| Date of dealing | 01 July 2021 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
| Class of relevant security: | ORD | ||||
| Long | Short | ||||
| Number | (%) | Number | (%) | ||
| (1) | Relevant securities | ||||
| 1,857,359 | 1.44% | 240,952 | 0.19% | ||
| (2) | Derivatives (other than options): | ||||
| 72,359 | 0.06% | 227,408 | 0.18% | ||
| (3) | Options and agreements to | ||||
| purchase/sell: | 6,100 | 0.00% | 6,100 | 0.00% | |
| TOTAL: | |||||
| 1,935,818 | 1.50% | 474,460 | 0.37% | ||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
| Class of relevant security: | Long | Short | ||||
| Number | (%) | Number | (%) | |||
| (1) Relevant securities | ||||||
| (2) Derivatives (other than options) | ||||||
| (3) Options and agreements to purchase/sell | ||||||
| Total | ||||||
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
| Purchase/sale | Number of relevant securities | Price per unit |
| Purchase | 2 | 231.7000 USD |
| Purchase | 2 | 231.1950 USD |
| Purchase | 25 | 231.2000 USD |
| Purchase | 28 | 231.4957 USD |
| Purchase | 35 | 231.2901 USD |
| Purchase | 54 | 231.4650 USD |
| Purchase | 56 | 231.2508 USD |
| Purchase | 81 | 231.2333 USD |
| Purchase | 100 | 231.0100 USD |
| Purchase | 100 | 231.4700 USD |
| Purchase | 100 | 231.4900 USD |
| Purchase | 200 | 232.6850 USD |
| Purchase | 210 | 231.1423 USD |
| Purchase | 400 | 231.1500 USD |
| Purchase | 800 | 231.0782 USD |
| Purchase | 837 | 230.9964 USD |
| Purchase | 1,037 | 231.1430 USD |
| Purchase | 1,158 | 231.2064 USD |
| Purchase | 1,265 | 230.9965 USD |
| Purchase | 1,319 | 231.0000 USD |
| Purchase | 1,497 | 231.1657 USD |
| Purchase | 2,833 | 230.9519 USD |
| Purchase | 3,504 | 231.7818 USD |
| Purchase | 5,232 | 231.2552 USD |
| Purchase | 5,450 | 231.2447 USD |
| Purchase | 8,828 | 231.0317 USD |
| Sale | 1 | 231.4500 USD |
| Sale | 1 | 231.1000 USD |
| Sale | 1 | 231.0700 USD |
| Sale | 2 | 231.3050 USD |
| Sale | 2 | 231.5800 USD |
| Sale | 19 | 231.1300 USD |
| Sale | 200 | 233.4875 USD |
| Sale | 200 | 232.6850 USD |
| Sale | 400 | 231.1500 USD |
| Sale | 444 | 231.5840 USD |
| Sale | 510 | 231.1222 USD |
| Sale | 529 | 231.1262 USD |
| Sale | 803 | 230.8920 USD |
| Sale | 1,021 | 231.1465 USD |
| Sale | 1,210 | 231.0615 USD |
| Sale | 1,267 | 230.9976 USD |
| Sale | 1,597 | 231.1848 USD |
| Sale | 1,634 | 231.0000 USD |
| Sale | 2,833 | 230.9519 USD |
| Sale | 2,860 | 231.6933 USD |
| Sale | 4,817 | 231.2966 USD |
| Sale | 4,921 | 231.2574 USD |
| Sale | 10,312 | 231.0579 USD |
(b) Derivatives transactions (other than options transactions)
| Product name, e.g. CFD |
Nature of transaction (Note 6) |
Number of relevant securities (Note 7) |
Price per unit (Note 5) |
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
| Product name, e.g. call option |
Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
(ii) Exercising
| Product name, e.g. call option |
Number of securities | Exercise price per unit (Note 5) |
(d) Other dealings (including transactions in respect of new securities) (Note 4)
| Nature of transaction (Note 8) |
Details | Price per unit (if applicable) (Note 5) |
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
| Is a Supplemental Form 8 (Open Positions) attached? | YES |
| Date of disclosure: | 2 Jul 2021 |
| Contact name: | Large Holdings Regulatory Operations |
| Telephone number: | 020 3134 7213 |
| If a connected EFM, name of offeree/offeror with which connected | |
| If a connected EFM, state nature of connection |
Ap23
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)
OPEN POSITIONS (Note 1)
| Product name | Written or | Number of | Exercise | Type | Expiry |
| purchased | relevant securities | price | date | ||
| to which the option | |||||
| or derivative | |||||
| relates | |||||
| Put Options | Purchased | -100 | 220.0000 | American | Jul 16, 2021 |
| Call Options | Purchased | 100 | 240.0000 | American | Jul 16, 2021 |
| Call Options | Purchased | 6,000 | 220.0000 | American | Jul 16, 2021 |
| Put Options | Purchased | -6,000 | 200.0000 | American | Jul 16, 2021 |
Notes
1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210702005200/en/
BARCLAYS PLC